|
Model Number PXB35-07-37-080 |
Device Problems
Difficult to Remove (1528); Difficult to Advance (2920); Device Dislodged or Dislocated (2923); Positioning Problem (3009)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 04/20/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Physician intended to use a visipro balloon expandable stent system during treatment of a 20mm calcified lesion in the patient¿s right superior mesenteric artery (sma) of diameter 7mm.Moderate vessel tortuosity and calcification are reported.Ifu was followed and the device was prepped without issue.It is reported resistance was encountered during advancement, but no excessive force was used.The device was unable to cross the lesion.The physician then attempted to pull the device back and the stent is reported to have dislodged from the balloon unknowingly.The physician then attempted to advance another wire and catheter and observed the unexpanded stent which had dislodged.The physician then attempted to use a snare kit to retrieve the unexpanded stent.The stent was captured but lost in the arterial wall.A cut-down was then performed to retrieve the stent.The physician then regained access successfully and placed a paramount mini stent at the target lesion to complete the procedure successfully.No patient injury reported.
|
|
Manufacturer Narrative
|
Additional information; all components of the device were removed from the patient's body.There was no vessel damage and the patient recovered successfully.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|